PATENT CLAIM ANALYSIS

Application Number: 16033395
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-04
Patent Classification: ["546", "119000"]

Abstract:
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

Claim (Index 7):
The compound or pharmaceutically acceptable salt thereof according to  claim 1 , wherein R4 is phenyl, pyridinyl or pyridonyl all of which can be optionally substituted one time with a substituent selected from the group consisting of halogen, C 1 -C 3  alkyl and C 1 -C 3  alkoxy.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.125
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15637920', '15849798', '16340429', '12303618', '14671531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.847615138717027
- 35 USC 102 Novelty (BERT): 0.6105026918774921
- Combined Prediction Score: 0.8239038940330735
- Mean Citation Score: 413.943516
- Max Citation Score: 574.4137
- Similarity Product: 499.5478481043338

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test